Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hepatitis B vaccines.

Andy S Yu¹, Ramsey C Cheung, Emmet B Keeffe

¹Pacific Gastroenterology, 2101 Forest Avenue, Suite 106, San Jose, CA 95128, USA.

Infectious Disease Clinics of North America

|March 11, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cost-Effectiveness of Blood-Based Fibrosis Screening in High-Risk Metabolic Liver Diseases With Emerging Therapies.

Gastro hep advances·2026

Same author

No Differences in Risk of Cirrhosis or Hepatocellular Carcinoma Among Treatment Naïve Chronic Hepatitis B Patients by Baseline Hepatitis B Viral Load: A Propensity Score Weighted Analysis.

Journal of clinical and experimental hepatology·2025

Same author

Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran Population.

The journal of applied laboratory medicine·2025

Same author

Association of Baseline Hepatitis B Virus DNA and On-Treatment Risk of Cirrhosis and Hepatocellular Carcinoma.

Gastroenterology research·2024

Same author

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Preventing Vertical Transmission in Chronic Hepatitis B Mothers: A Systematic Review and Meta-Analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024

Same author

Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta-analysis.

Journal of viral hepatitis·2024

Hepatitis B vaccination is highly effective in preventing hepatitis B virus (HBV) infection and is recommended for all age groups. While generally safe and achieving high seroprotection rates, factors like age and health status can affect vaccine response.

Area of Science:

Immunology
Public Health
Vaccinology

Background:

Hepatitis B virus (HBV) infection poses a significant public health risk, leading to acute or chronic hepatitis B.
Immunization is the primary strategy for preventing HBV transmission and its sequelae.
National strategies aim to eliminate HBV transmission through widespread vaccination programs.

Purpose of the Study:

To outline the current national strategy for HBV elimination in the United States.
To review the efficacy, safety, and response predictors of hepatitis B vaccination.
To discuss management strategies for non-responders to vaccination.

Main Methods:

Review of national immunization guidelines and strategies for HBV prevention.
Analysis of seroprotection rates and adverse effects associated with hepatitis B vaccines.

Related Experiment Videos

Identification of factors associated with vaccine non-response.

Main Results:

Hepatitis B vaccination is recommended for all infants, children, adolescents, and high-risk adults.
Seroprotection (anti-HBs ≥ 10 mIU/mL) is achieved in over 95% of vaccinees.
Predictors of non-response include older age, male gender, obesity, smoking, and immunocompromising conditions.

Conclusions:

Hepatitis B vaccination is a safe and highly effective method for preventing HBV infection.
Vaccination is a cornerstone of the national strategy to eliminate HBV transmission.
Further strategies, including adjuvants, may be considered for persistent vaccine non-responders, though results are variable.